Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids ...

Supported by an independent educational grant from Boehringer Ingelheim and Pfizer. Mrs. Sweet is a 51-year-old woman who presents to your office with the chief complaint of shortness of breath and ...

Although there is significant improvement in managing asthma and chronic obstructive pulmonary disease (COPD) diseases, there is still a strong need in controlling symptoms to prevent hospitalizations ...

The first generic version of Symbicort -- a metered-dose inhaler that combines the corticosteroid budesonide with the long-acting bronchodilator formoterol -- has been approved for asthma and chronic ...

Current drug treatments have been incorporated into clinical practice guidelines, such as the NAEPP EPR-3 for asthma [101] and GOLD treatment guidelines for COPD, [102] both of which recognize the ...

GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick relief and daily control.

Researchers have discovered that people with asthma and chronic obstructive pulmonary disease have a protein in their lungs that leaks a small molecule into their bloodstream that restricts their ...

Please provide your email address to receive an email when new articles are posted on . In a cohort of individuals with respiratory symptoms, 21% had undiagnosed COPD or asthma. Researchers found ...

The first inhaled corticosteroids were developed in 1972 for use in people with asthma. The drugs, which tackle inflammation in the airways, were revolutionary in reducing the number of hospital ...